All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
As a trail-blazing pioneer in biologics, Amgen Inc. has the unenviable position of having to mark the patent protection path against biosimilars targeting its legacy products.
